Tanaka Growth Fund (TGFRX)
| Fund Assets | 40.02M |
| Expense Ratio | 1.95% |
| Min. Investment | $2,000 |
| Turnover | 23.35% |
| Dividend (ttm) | 7.39 |
| Dividend Yield | 11.34% |
| Dividend Growth | 134.23% |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 18, 2025 |
| Previous Close | 65.19 |
| YTD Return | 16.54% |
| 1-Year Return | 48.08% |
| 5-Year Return | 86.92% |
| 52-Week Low | 50.73 |
| 52-Week High | 72.84 |
| Beta (5Y) | 1.23 |
| Holdings | 24 |
| Inception Date | Dec 30, 1998 |
About TGFRX
The Tanaka Growth Fund Class R is a mutual fund focused on achieving capital growth through investments primarily in common stocks and equity securities across small, medium, and large capitalization companies. Managed by Tanaka Capital Management, the fund actively seeks out companies that its investment advisor believes have strong growth potential, both within the United States and internationally—allocating up to 45% of its assets to foreign and emerging market securities. As a non-diversified fund, Tanaka Growth Fund Class R often takes concentrated positions in a select group of holdings, leading to an overweight in certain key sectors, most notably technology, healthcare, and financial services. This investment approach allows the fund to capitalize on high-conviction opportunities. Due to its non-diversified structure and sector emphasis, the fund may experience periods of higher volatility compared to diversified funds. It carries a relatively high expense ratio, reflecting its active management style. The fund’s portfolio is characterized by a significant portion of assets allocated to top holdings, underscoring its targeted growth strategy and focused approach to capital appreciation.
Performance
TGFRX had a total return of 48.08% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.83%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
| Symbol | Provider | Name | Expense Ratio |
|---|---|---|---|
| FZROX | Fidelity | Fidelity ZERO Total Market Index Fund | n/a |
Top 10 Holdings
55.77% of assets| Name | Symbol | Weight |
|---|---|---|
| United States Antimony Corporation | UAMY | 7.82% |
| Nuvation Bio Inc. | NUVB | 7.72% |
| NVIDIA Corporation | NVDA | 6.65% |
| NexGen Energy Ltd. | n/a | 6.56% |
| Aura Minerals Inc. | AUGO | 6.42% |
| Corcept Therapeutics Incorporated | CORT | 5.02% |
| Apple Inc. | AAPL | 4.67% |
| Applied Materials, Inc. | AMAT | 3.88% |
| Intellia Therapeutics, Inc. | NTLA | 3.71% |
| Symbotic, Inc. Class A | n/a | 3.32% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 18, 2025 | $7.39348 | Dec 18, 2025 |
| Dec 27, 2024 | $3.15651 | Dec 27, 2024 |
| Dec 27, 2022 | $0.03145 | Dec 27, 2022 |